PedAM
Pediatric Disease Annotations & Medicines
| Disease | encephalopathy |
| Phenotype | C0023890|liver cirrhosis |
| Sentences | 35 |
| PubMedID- 21757988 | This case shows that caution should be exercised when administering metronidazole because even a low dose can induce encephalopathy in patients with liver cirrhosis. |
| PubMedID- 25420740 | However, it is often very difficult to differentiate between cryptococcal meningitis and hepatic encephalopathy in patients with liver cirrhosis, and there is delay in making the diagnosis. |
| PubMedID- 23626595 | Even if a patient has liver cirrhosis with hepatic encephalopathy, liver cirrhosis should not be considered to be the only cause of hyperammonemia. |
| PubMedID- 22870180 | In conclusion, we experienced mnz-induced encephalopathy developed in patients with liver cirrhosis. |
| PubMedID- 23967390 | Furthermore, it is used for prophylaxis of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 25932262 | Aim: to determine the effects of small-intestinal bacterial overgrowth (sibo) and rifaximin therapy on minimal hepatic encephalopathy (mhe) with liver cirrhosis. |
| PubMedID- 20216550 | Increased blood-brain barrier (bbb) permeability for ammonia is considered to be an integral part of the pathophysiology of hepatic encephalopathy (he) in patients with liver cirrhosis. |
| PubMedID- 25867912 | Objective: to determine the efficacy of rifaximin once a day dose in the prevention of hepatic encephalopathy (he) in patients with liver cirrhosis as compared with twice daily dose of rifaximin. |
| PubMedID- 20642112 | Low doses are used as a food supplement and high doses (above 5 g) as a medicinal product to lower blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis. |
| PubMedID- 21483460 | 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 22384773 | Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis. |
| PubMedID- 26516441 | In our study, hyponatremia was associated with increased incidence of hepatic encephalopathy in patients with decompensated liver cirrhosis. |
| PubMedID- 20010298 | Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 22734925 | Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: occlusion of portosystemic shunt in combination with splenectomy. |
| PubMedID- 23414576 | In pharmacological therapy, ornithine is used to decrease blood ammonia concentrations and reduce the symptoms of hepatic encephalopathy associated with liver cirrhosis[6]. |
| PubMedID- 24078984 | Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 23225825 | Previously studies have investigated the effect of propofol on sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis.11,18 these studies found that propofol sedation during upper gastrointestinal endoscopy did not cause acute deterioration of sub-clinical hepatic encephalopathy.11,18 however, in patients with liver cirrhosis, hepatic function reserve is quite limited, and a cirrhotic liver is less tolerant to hemodynamic changes and surgical stress.1 therefore, anesthetic agents should be titrated with caution in cirrhotic patients to minimize the adverse effects of drugs and to stabilize hemodymanics. |
| PubMedID- 25863779 | Patients with hepatic encephalopathy in liver cirrhosis and healthy controls ingested a 20-g solution of glutamine dissolved in 100 ml of tap water. |
| PubMedID- 25674427 | Supplementation with bcaas normalizes amino acid profiles, ameliorates complications such as encephalopathy and hypoalbuminemia in patients with liver cirrhosis (kawaguchi et al. |
| PubMedID- 25100119 | Conclusion: probiotics decrease overt hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 19903725 | Standardized nomenclature has been proposed but a standardized approach to the treatment, particularly of persistent, episodic and recurrent encephalopathy associated with liver cirrhosis has not been proposed. |
| PubMedID- 21978390 | Systemic translocation of gut-derived bacteria and their products is a risk factor for recurrent spontaneous bacterial peritonitis and/or encephalopathy in patients with liver cirrhosis [1,2]. |
| PubMedID- 21416318 | Pylori) bacteria convert urea to ammonia, which has been implicated in causation of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 20506574 | Wernicke encephalopathy following splenectomy in a patient with liver cirrhosis: a case report and review of the literature. |
| PubMedID- 25459346 | Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes. |
| PubMedID- 25847088 | Aim: to examine whether the brain exhibits metabolic disorder prior to overt hepatic encephalopathy in patients with liver cirrhosis (lc), the intracerebral glutamine and myo-inositol levels were determined using 3.0-tesla (t)1 h (proton) magnetic resonance spectroscopy (mrs). |
| PubMedID- 24709242 | Objective: to determine the efficacy of rifaximin in prevention of repeated episodes of hepatic encephalopathy in patients with liver cirrhosis as compared to placebo. |
| PubMedID- 24974838 | Infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension. |
| PubMedID- 25420513 | Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension. |
| PubMedID- 20852922 | The mean cff was higher in patients after liver transplantation, but did not reach statistical significance.table 2surrogate markers for hepatic encephalopathy in patients with liver cirrhosis and those who have received liver transplants. |
| PubMedID- 23742732 | Prospective randomized clinical trials that compared the effects of zinc supplementation with those of no intervention, placebo, or standard therapy on hepatic encephalopathy in patients with liver cirrhosis were included. |
| PubMedID- 25509200 | The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 25060166 | Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted mr imaging and proton mr spectroscopy of the brain. |
| PubMedID- 20934771 | Conclusions: sedation with propofol has a shorter time recovery and a shorter time to discharge than midazolam and does not exacerbate sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis. |
| PubMedID- 20482828 | Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin ii receptor blocker combination therapy: a case report. |
Page: 1